email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2641-1687

Journal of Urology & Nephrology Studies

Research Article(ISSN: 2641-1687)

Private Health Insurance is a FavourablePrognostic Risk Factor in the Outcomes of Mortality Post Radical C ystectomy

Volume 3 - Issue 1

Simon Robinson*, Ailsa Butler, Mufeed Ali and Hanif Motiwala

  • Author Information Open or Close
    • FHFT Department Urology, Oxon dept epidemiology Oxford, Frimley health foundation trust, UK

    *Corresponding author: Simon Robinson, Frimley health foundation trust, FHFT Department Urology, Oxon dept epidemiology Oxford, FHFT Dept Pathology, UK

Received: July 27, 2020;   Published: August 07, 2020

DOI: 10.32474/JUNS.2020.03.000151

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Objectives: There are well recognised differences in health outcomes generally in society due to a range of socio-economic factors. We have compared survival outcomes in patients undergoing radical cystectomy for aggressive bladder cancer in the national health service (NHS) and compared this with those with private health insurance (PHI).

Methods: This is retrospective study of 225 NHS and 32 PHI patients operated over 14 years by one surgeon. ASA scores were compared to approximate comorbidity status.

Results: There were significantly worse outcomes for all cause and disease specific mortality in the NHS group. There was no difference in ASA scores.

Conclusions: NHS patients fare worse than those with PHI. The reasons for this difference remain unclear. PHI patients have a more extensive lymphadenectomy and have fewer overall complications.

Keywords: NHS private insurance outcomes radical cystectomy bladder cancer

Abstract| Introduction| Methods| Results| Discussion| Progression| Conclusions| Limitations| References|